<?xml version="1.0" encoding="UTF-8"?>
<ref id="B37-ijms-22-01285">
 <label>37.</label>
 <element-citation publication-type="journal">
  <person-group person-group-type="author">
   <name>
    <surname>Sheffler</surname>
    <given-names>D.J.</given-names>
   </name>
   <name>
    <surname>Williams</surname>
    <given-names>R.</given-names>
   </name>
   <name>
    <surname>Bridges</surname>
    <given-names>T.M.</given-names>
   </name>
   <name>
    <surname>Xiang</surname>
    <given-names>Z.</given-names>
   </name>
   <name>
    <surname>Kane</surname>
    <given-names>A.S.</given-names>
   </name>
   <name>
    <surname>Byun</surname>
    <given-names>N.E.</given-names>
   </name>
   <name>
    <surname>Jadhav</surname>
    <given-names>S.</given-names>
   </name>
   <name>
    <surname>Mock</surname>
    <given-names>M.M.</given-names>
   </name>
   <name>
    <surname>Zheng</surname>
    <given-names>F.</given-names>
   </name>
   <name>
    <surname>Lewis</surname>
    <given-names>L.M.</given-names>
   </name>
  </person-group>
  <article-title>A novel selective muscarinic acetylcholine receptor subtype 1 antagonist reduces seizures without impairing hippocampus-dependent learning</article-title>
  <source>Mol. Pharmacol.</source>
  <year>2009</year>
  <volume>76</volume>
  <fpage>356</fpage>
  <lpage>368</lpage>
  <pub-id pub-id-type="doi">10.1124/mol.109.056531</pub-id>
  <pub-id pub-id-type="pmid">19407080</pub-id>
 </element-citation>
</ref>
